Company News

Formal Signing of the Contract for “Gan & Lee - Linyi Production Base”

  • Time: 2019-10-12 11:35:56
  • Click Rate: 2915

Beijing – Gan & Lee Pharmaceuticals (“ Gan & Lee ”) announced that it formally signed a contract to establish a “Gan & Lee - Linyi Production Base ” in Shandong Province on 19th September , 2019. After more than 20 years of rapid development near Beijing, Gan & Lee regards LinyiLinyi is in the Province of Shandongas its second largest pharmaceutical production base in China in accord with its development strategy of internationalization and industrialization.

Gan & Lee adheres to the enterprise spirit of The Persistence of Science,The Pursuit of Perfection to enhance its products in the fields of diabetes, hematology, cancer and other areas making use of the advantages of policy and geography provided by the Linyi Development Zone. Gan & Lee is dedicated to providing high-quality products and services to patients worldwide.

 

 Signing Ceremony

About Gan & Lee

Gan & Lee Pharmaceuticals is a high-tech biopharmaceutical company specialized in research, development, production and commercialization of insulin and its analogues, and is a leading company in the diabetes market in China. With the advantages of technology and lower cost Gan & Lee has expanded rapidly into the global market. Overseas business has expanded to cover about 20 countries and regions. Gan & Lee adheres to the enterprise spirit of The Persistence of Science,The Pursuit of Perfection”. Gan & Lee devotes itself to research and development of drug products in the fields of diabetes, hematology, and cancer and other areas to provide diversified and high-quality pharmaceutical products and services to benefit patients worldwide.

 

Gan & Lee Media Relations

 

Zijia Chen

 

Central media line: +86 010 56965167

E-mail: ir@ganlee.com